AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06507995 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: thoracic interlaminar epidural injection
Description: . Injections were administered under sedation and sterile conditions, with all patients positioned prone and monitored. A single physician performed all injections using an 18 gauge Tuohy needle, employing the loss of resistance technique and confirming the epidural space placement with 5 mL of nonionic contrast.
Study NCT06601231 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: GAAD score
Description: In order to calculate the GAAD score an in-vitro diagnostic is used. The Elecsys GAAD assay by Roche Diagnostics is used to assess the GAAD score using on blood samples collected from patients during regular outpatient clinic visits. The Elecsys GAAD test combines the results of the Elecsys PIVKA-II and Elecsys AFP assays with gender and age (the GAAD score is calculated with PIVKA-II, AFP, gender and age).
Study NCT06603376 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FOLFIRI + Vemurafenib + Cetuximab
Description: Liposomal Irinotecan Hydrochloride Injection (II): 60 mg/m², intravenous infusion over at least 90 minutes, on day 1; Leucovorin: 400 mg/m², intravenous infusion over 2 hours, on day 1; 5-FU: 400 mg/m², intravenous bolus; 5-FU: 2400 mg/m², continuous infusion over 46-48 hours, on day 1; Cetuximab: 500 mg/m², intravenous infusion over at least 2 hours, on day 1; Vemurafenib: 720 mg, orally twice daily. Repeat every 2 weeks.
Study NCT06603376 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FOLFIRI ± Bevacizumab
Description: Liposomal Irinotecan Hydrochloride Injection (II): 60 mg/m², intravenous infusion over at least 90 minutes, on day 1; Leucovorin: 400 mg/m², intravenous infusion over 2 hours, on day 1; 5-FU: 400 mg/m², intravenous bolus; 5-FU: 2400 mg/m², continuous infusion over 46-48 hours, on day 1; Bevacizumab: 5 mg/kg, intravenous infusion, on day 1. Repeat every 2 weeks.
Study NCT06604403 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Massage
Description: After the hemodialysis, the patients will receive a 15-20 minute hand and foot massage. This application will be applied to the patients in two weekly dialysis sessions for a total of 8 sessions for four weeks. Before starting the massage applications, the patient's hands and feet will be washed and dried thoroughly. The patients will be given a semi-sitting or lying position that they can feel comfortable in. Before starting the hand and foot massage, the researcher will gently rub and warm their hands and wrists. The massages will start with a hand massage. A foot massage will be performed after the hand massage. 3-5 drops of baby oil applied at room temperature will be used to reduce friction during the massage. Effleurage, petrissage and friction styles of the massage will be applied.
Study NCT06259916 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alcohol
Description: Participants in this condition will receive the standard alcohol dose
Study NCT06259916 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cannabis
Description: Participants in this group will self-administer legal-market flower cannabis
Study NCT04949490 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BNT162b2s01
Description: intramuscular (IM) injection
Study NCT04949490 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BNT162b2
Description: IM injection
Study NCT06599424 — intervention group
Intervention type: OTHER
Intervention: Observational
Description: Observational
Study NCT06589570 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Removable Partial Denture
Description: A removable partial denture (RPD) is a dental prosthesis designed to replace one or more missing teeth in the mouth. Unlike full dentures, which are used when all teeth are missing, an RPD is specifically made for patients who still have some of their natural teeth remaining. It restores both function and aesthetics, allowing patients to chew, speak, and smile with greater confidence.
Study NCT06589570 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Removable Partial Denture
Description: A removable partial denture (RPD) is a dental prosthesis designed to replace one or more missing teeth in the mouth. Unlike full dentures, which are used when all teeth are missing, an RPD is specifically made for patients who still have some of their natural teeth remaining. It restores both function and aesthetics, allowing patients to chew, speak, and smile with greater confidence.
Study NCT06544824 — intervention group
Intervention type: OTHER
Intervention: Measure gait spatiotemporal parameters and kinematics from optoelectronic system
Description: The raw data acquired from motion capture system were processed with Smart Analyzer software (BTS Bioengineering, Milano, Italy). First, the 3D data were filtered and interpolated in case of missing data for short time. Then spatial-temporal parameters (cycle duration, cadence, gait speed, stance phase, swing phase, double-support phase, stride length and step width) and conventional kinematic parameters of traditional Davis marker-set protocols were computed.
Study NCT06544824 — intervention group
Intervention type: OTHER
Intervention: Measure gait spatiotemporal parameters and kinematics from markerless system
Description: The two videos were elaborated using OpenPose that returns a set of 25 2D keypoints coordinates for body pose estimation for each video. Key-points were located in relevant body landmarks and it were used to determine the 2D Cartesian coordinates on the sagittal plane and on the frontal plane. The data calculated with routines were filtered and interpolated in case of missing data. With respect to kinematic parameters, the segment and joint angles were measured from the estimated feature points of each joint. Spatiotemporal gait parameters were calculated using successive heel strike and toe-off events.
Study NCT06592027 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: PRECEDEX INJ★ 2ML
Description: this group will receive single dose of dexmedetomidine 0.5 mcg /kg in 50 ml normal saline over 10 min IV infusion
Study NCT06592027 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PRECEDEX INJ★ 2ML
Description: single dose of dexmedetomidine 1 mcg /kg in 50 ml normal saline over 10 min IV infusion
Study NCT05755516 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Self-expanding Intracranial Stent (Tonbridge)
Description: Stent assisted coiling with Self-expanding Intracranial Stent (Tonbridge).
Study NCT05755516 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: LVIS and LVIS Jr. (MicroVention)
Description: Stent assisted coiling with LVIS and LVIS Jr. (MicroVention).
Study NCT06470711 — intervention group
Intervention type: OTHER
Intervention: Non-Interventional Study
Description: Non-interventional study
Study NCT06004739 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Start Antibiotics / Continue Antibiotics for treatment of bacteriuria
Description: Participants will be randomized to start or continue with antibiotics (with antibiotic duration determined by the Most Responsible Physician \[MRP\]). Antibiotics choice to be selected by the MRP.
Study NCT06004739 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No Antibiotics for treatment of bacteriuria
Description: Participants will be randomized to no antibiotics
Study NCT04806464 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
Description: Intratumoral injection only. The dosing date can be the Day 1 only or Days 1 through 5.
Study NCT05259020 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ID140009
Description: Combination Product: ID140009 Ezetibmibe 10mg/ Rosuvastatin Ca 20.8mg/ Amlodipine 10mg/ Valsartan 160mg
Study NCT05259020 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: ID1803+ID1805
Description: (Amlodipine 10mg/Valsartan 160mg)+(Ezetibmibe 10mg/ Rosuvastatin Ca 20.8mg)
Study NCT05764928 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BLEX 404
Description: BLEX 404 Oral Liquid, PO, BID
Study NCT05560100 — intervention group
Intervention type: OTHER
Intervention: Nominal Group Technique - 2 to 3 hour virtual meeting
Description: Participants will be invited to a 2-3 online virtual online meeting with the goal of constructing and defining elements for producing a risk statement for dry needling that can be used for informed consent.
Study NCT05143983 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Positive valence music
Description: Subjects will have to listen to 3 minutes of unfamiliar musical excerpts, with positive valence characteristics (fast tempo, major key). They will be told to listen carefully in order to then answer a short questionnaire. The listening will be followed by an liking scale (from 1 : not liked at all, to 5 : liked a lot) and a familiarity scale (from 1 : not familiar at all, to 5 : very familiar).
Study NCT05143983 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Positive valence music
Description: Subjects will have to listen to 3 minutes of unfamiliar musical excerpts, with positive valence characteristics (fast tempo, major key). They will be told to listen carefully in order to then answer a short questionnaire. The listening will be followed by an liking scale (from 1 : not liked at all, to 5 : liked a lot) and a familiarity scale (from 1 : not familiar at all, to 5 : very familiar).
Study NCT05143983 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Neutral valence music
Description: Subjects will have to listen to 3 minutes of unfamiliar musical excepts with neutral valence. They will be told to listen carefully in order to then answer to a short questionnaire. The listening will be followed by a liking scale (from 1 : not liked at all, to 5 : liked a lot) and a familiarity scale (from 1 : not familiar at all, to 5 : very familiar).
Study NCT05302349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core Exercise Group
Description: Core Exercise Group Procedure:~Weeks 1-4 (Five days a week)~1. Hotpack ultrasound, conventional TENS, stretching exercises and strengthening exercises for low back pain.~2. Core stabilization exercise :~   * Active pelvic floor exercise (supine position)~  * Bridge exercise (supine position)~  * Back Extension and Ball Back Extension exercises (prone position)~  * Abdominal and Oblique Crunch exercises (supin position)~  * Leg lift exercise (prone position)~  * Plank and Side Plank exercise~  * Superman exercise~Weeks 5-8 (Three days a week)~1. Stretching exercises and strengthening exercises for low back pain.~2. Core stabilization exercise :~   * The same exercises as for Weeks 1-4 will perform.
Study NCT05302349 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine Therapy Group
Description: Routine Therapy Group Procedure:~Weeks 1-4 (Five days a week)~1. Hotpack ultrasound, conventional TENS, stretching exercises and strengthening exercises for low back pain.~Weeks 5-8 (Three days a week)~1.Stretching exercises and strengthening exercises for low back pain.
Study NCT05955313 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naltrexone Hydrochloride
Description: treatment of vulvodynia
Study NCT05955313 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Naltrexone Hydrochloride
Description: treatment of vulvodynia
Study NCT05507931 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 1 Serving of broccoli sprouts
Description: Participants will take 1 serving of broccoli sprouts daily for 28 days. The sprouts will be provided by the study team along with instructions on how to prepare the steamed broccoli sprouts (i.e., steamed for 10 minutes). In addition to taking the sprouts, participants will be asked to complete food diaries and surveys, collect blood and stool samples, as well as having 2 in-person visits.
Study NCT05507931 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 3 Servings of broccoli sprouts
Description: Participants will take 3 servings of broccoli a day for 28 days. The sprouts will be provided by the study team along with instructions on how to prepare the steamed broccoli sprouts (i.e., steamed for 10 minutes). In addition to taking the sprouts, participants will be asked to complete food diaries and surveys, collect blood and stool samples, as well as having 2 in-person visits.
Study NCT06486038 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRI standard and qMRI
Description: Non-contrast cervical spine MRI including morphological and quantitative MRI sequences on a 3 Tesla scanner. MRI examination includes conventional and experimental sequences
Study NCT06486038 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MEPs and SSEPs
Description: Neurophysiological examination by motor and somatosensorial evocked potential using transcranial magnetic stimulation and electrical stimulation to the peripheral nerve
Study NCT06486038 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neuromotor assessment
Description: Upper and Lower limb assessment: Purdue Pegboard Test (PTT), Box and Block test (BBT), Nine Hole Peg Test (NHPT), gait analysis and 30 seconds sit to stand test (30CST)
Study NCT06486038 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Anterior cervical discectomy and fusion
Description: If applicable: Anterior cervical discectomy and fusion surgery using PEEK or modern carbon fiber material
Study NCT05709795 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Confluent areas
Description: Use of omnipolar technology to guide CTI ablation in sites with both low wave speed and high voltage. If not successful then ablation of low wave speed sites. If not successful then ablation of high voltage sites. If not successful then CTI line (gold standard)
Study NCT05709795 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Wave Speed
Description: Use of omnipolar technology to guide CTI ablation in sites with low wave speed. If not successful then ablation of sites with both low wave speed and high voltage. If not successful then ablation of high voltage sites. If not successful then CTI line (gold standard)
Study NCT05709795 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Voltage
Description: Use of omnipolar technology to guide CTI ablation in sites with high voltage. If not successful then ablation of sites with both low wave speed and high voltage. If not successful then ablation of low wave speed sites. If not successful then CTI line (gold standard)
Study NCT05709795 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: CTI line
Description: Do not use omnipolar information. CTI line performance
Study NCT04900987 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Steri-strips
Description: Pneumatic TR band compression with use of steri-strips
Study NCT05488574 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Deep breathing with Yoga positioning
Description: Deep breathing with yoga positioning 10min in morning, 1 minute noon, and 1 minute evening (diner)
Study NCT05482997 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Whey Protein Concentrate
Description: whey-based protein powder 32g powder mixed with 8-12 oz water
Study NCT05482997 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Pea Protein Isolate, Rice Protein Concentrate, Hemp Protein
Description: plant-based protein powder. 32g powder mixed with 8-12 oz water
Study NCT05368051 — intervention group
Intervention type: COMBINATION_PRODUCT
Intervention: long course radiotherapy + capecitabine + PD-1 monoclonal antibody
Description: long course radiotherapy + capecitabine + PD-1 monoclonal antibody treatment combinations in patients with locally advanced rectal cancer
Study NCT05694572 — intervention group
Intervention type: DEVICE
Intervention: Implantation of a CIED
Description: Implantation of a CIED
Study NCT06324565 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: D-Dimer test
Description: All patients in whom preoperative diagnostics have not been able to exclude a surgical pathology and who are candidates for diagnostic-therapeutic surgery will be referred for minimally invasive abdominal exploration in the real suspicion of ovarian torsion. During the pre-operative phase, blood exams will be performed including coagulation which will be integrated with the D-dimer values. In addition, as usual, the clinical examination of the patients will be performed integrated with the various diagnostic image tools generally used in this category of patients (abdomen ultrasound +/- magnetic resonance in urgency).
Study NCT05198908 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VR group
Description: Women in this group will wear virtual reality glasses (15-20 minutes) until the episiotomy repair begins and ends. At the same time, the hospital protocol will be applied to this group.~Before episiotomy repair, each woman is given superficial perineal anesthesia with a 4 ml ampoule of Jetocaine (ADEKA®, lidocaine HCl 40 mg/2 mL, epinephrine 0.025 mg/2 mL). This dose is repeated if necessary.
Study NCT05198908 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Skin to skin group
Description: For women in this group, a warm sterile operating room towel will be placed on the newborn until the episiotomy repair begins and ends, so that her naked body remains on the mother's chest.At the same time, the hospital protocol will be applied to this group.~Before episiotomy repair, each woman is given superficial perineal anesthesia with a 4 ml ampoule of Jetocaine (ADEKA®, lidocaine HCl 40 mg/2 mL, epinephrine 0.025 mg/2 mL). This dose is repeated if necessary.
Study NCT06328803 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation training
Description: Including 1) Basic treatment, including corresponding control of risk factors and education on healthy lifestyles. 2)Swallowing training, including lemon ice stimulation, mendelson maneuver, empty swallowing training, and pronunciation training.
Study NCT06328803 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rehabilitation training
Description: Including 1) Basic treatment, including corresponding control of risk factors and education on healthy lifestyles. 2)Swallowing training, including lemon ice stimulation, mendelson maneuver, empty swallowing training, and pronunciation training.
Study NCT06328803 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active Breathing Exercises
Description: Active breathing exercises aim to enhance the strength and flexibility of respiratory muscles through a series of exercises, improving breathing patterns and increasing respiratory efficiency. The following are common components of active breathing exercises: 1) Deep Breathing. 2) Chest Expansion. 3) Diaphragmatic Breathing. 4) Coughing Techniques. 5) Expiratory Resistance Training. 6) Gradual Increase in Activity.
Study NCT05231031 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic exercise
Description: continuous aerobic exercise on a treadmill
Study NCT05231031 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Description: continuous aerobic exercise on a treadmill
Study NCT05231031 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: breathing exercise
Description: continuous aerobic exercise plus breathing exercise (Mindfulness)
Study NCT05231031 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relaxation training
Description: continuous aerobic exercise plus relaxation training
Study NCT05532982 — intervention group
Intervention type: OTHER
Intervention: Interviews and Surveys
Description: Qualitative interviews and surveys
Study NCT06349928 — intervention group
Intervention type: OTHER
Intervention: Focus group or interview
Description: Focus groups and qualitative interview will be conducted with dancers investigating thoughts, beliefs and behaviors related to injury. Individual interviews (in presence or online) will be hold as alternative if it will not be possible (due to logistical or personal problems) to participate in a focus group or if the number of people who would have agreed to participate in that focus group is less than 3
Study NCT06266884 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kangaroo care
Description: Kangaroo care is a safe and effective method in which the baby is placed in an upright position on the parent's bare chest, wearing only a diaper and a hat, and the baby's needs for nutrition, warmth, love and trust are met and provides positive interaction between the parent and the baby.
Study NCT06375707 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: physician's choice of chemotherapy sequential Ribociclib combined with NSAI±OFS
Description: Docetaxel: 100mg/m2 IV every 21 days Paclitaxel: 175mg/m2 every 21 days, IV drip Vinorelbine: 25mg/ m2 on days 1 and 8 of each cycle, 1 cycle in 21 days, IV drip Capecitabine: 1000mg/m2, 2 times/d, 2 consecutive weeks of oral discontinuation for 1 week.~Ribociclib: 600mg /d, 3 weeks continuous oral withdrawal for 1 week NSAI: Anastrozole 1mg, 1 time /d, oral or Letrozole: 2.5mg, 1 time /d, oral
Study NCT06375707 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ribociclib combined with NSAI±OFS
Description: Ribociclib: 600mg /d, 3 weeks continuous oral withdrawal for 1 week NSAI: Anastrozole 1mg, 1 time /d, oral or Letrozole: 2.5mg, 1 time /d, oral
Study NCT05190718 — intervention group
Intervention type: DEVICE
Intervention: Pharyngeal electrostimulation
Description: Routine treatment:~Pharyngeal stimulation is performed via a nasogastric probe (Phagenyx) for a duration of 10 minutes daily and for at least 3 consecutive days. The number of stimulation repeats until max 2x3 repeats, depends on therapy progress and an interdisciplinary re-evaluation of the patient's rehabilitation potential.
Study NCT05140941 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet
Description: One Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet taken once daily for 84 days.
Study NCT05584267 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiotherapy
Description: Different cohorts received different doses of radiotherapy
Study NCT05584267 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy + immunotherapy
Description: Chemotherapy + immunotherapy